Method to increase class I presentation of exogenous antigens by human dendritic cells

Details for Australian Patent Application No. 2001259760 (hide)

Owner Northwest Biotherapeutics, Inc.

Inventors Salgaller, Michael L.; Boynton, Alton L.

Agent Griffith Hack

Pub. Number AU-B-2001259760

PCT Pub. Number WO01/87325

Priority 60203758 12.05.00 US

Filing date 11 May 2001

Wipo publication date 26 November 2001

Acceptance publication date 5 October 2006

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

10 July 2003 Amendment Made

  The nature of the amendment is: Amend the name of the applicant/patentee from NorthWest Biotherapeutics, Inc. to Northwest Biotherapeutics, Inc.

5 October 2006 Application Accepted

  Published as AU-B-2001259760

1 February 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001259762-Vapor proof high speed communications cable and method of manufacturing the same

2001259759